March 27, 2024 - The Supreme Court of the United States (SCOTUS) has yet to decide on mifepristone access in the US; however, many predict that the decision will come by late spring, June or July 2024 at the latest. Public opinion also predicts that the justices will side with the FDA on this decision, based on the rhetoric throughout the hearings.
On Tuesday,...
March 20, 2024 - On March 19, 2024, AstraZeneca entered into a definitive agreement to acquire Fusion Pharmaceuticals in a $2 billion deal. Through this deal, AstraZeneca will expand its portfolio and gain access to Fusion’s clinical-stage, next-generation radioconjugates and research that have been used in oncology treatments.
According to the American...
March 15, 2024 - Amazon Pharmacy will now be filling prescriptions for glucagon-like peptide-1 (GLP-1) drugs — and other pharmaceuticals for obesity, diabetes, and migraines — requested through Eli Lilly’s LillyDirect platform, according to an announcement by Lilly on March 13, 2024. The pharmacy will join TruePill as one of the platform’s...
March 13, 2024 - On March 6, 2024, Valisure, an independent quality assurance lab, issued a press release identifying harmfully high levels of benzoyl peroxide in multiple skincare products, specifically products marketed for acne. The press release notes that at high levels, benzoyl peroxide can form into benzene, an established human carcinogen, at concentrations...